The case for treatment of monogenic SRNS with calcineurin inhibitors
Kidney International · 2023
DOI: 10.1016/j.kint.2023.02.017 ↗Kurz gefasst
Kommentar in der Zeitschrift Kidney International, 2023. Verfasst von Brandon M Lane und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, North Carolina, USA; Duke Molecular Physiology Institute, D…. Hauptthemen laut MEDLINE: Calcineurin Inhibitors, Nephrotic Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Currently, no evidence-based guidelines exist for treatment of children with monogenic steroid-resistant nephrotic syndrome. A retrospective study on 141 patients from Malakasioti et al. revealed that 27.6% responded to calcineurin inhibitor (CNI) treatment, and 75% of responders maintained stable kidney function. Virtually all CNI nonresponders developed progressive loss of kidney function. This study emphasized roles for CNIs in patients with monogenic steroid-resistant nephrotic syndrome, and the need for future studies to identify CNI response biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, North Carolina, USA; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Pediatrics, Division of Nephrology, Duke University Medical Center, Durham, North Carolina, USA; Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA. Electr…
Förderung
- NIDDK NIH HHS
- NICHD NIH HHS
- National Institutes of Health
- NIDDK
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Lane, B. M., & Gbadegesin, R. A. (2023). The case for treatment of monogenic SRNS with calcineurin inhibitors. Kidney International. https://doi.org/10.1016/j.kint.2023.02.017
Vancouver
Lane BM, Gbadegesin RA. The case for treatment of monogenic SRNS with calcineurin inhibitors. Kidney International. 2023. doi:10.1016/j.kint.2023.02.017
BibTeX
@article{Lane2023,
author = {Lane, Brandon M and Gbadegesin, Rasheed A},
title = {The case for treatment of monogenic SRNS with calcineurin inhibitors},
journal = {Kidney International},
year = {2023},
doi = {10.1016/j.kint.2023.02.017}
}
EUVIMED